208 related articles for article (PubMed ID: 24925606)
1. Antipsychotic-induced parkinsonism is associated with working memory deficits in schizophrenia-spectrum disorders.
Potvin S; Aubin G; Stip E
Eur Arch Psychiatry Clin Neurosci; 2015 Mar; 265(2):147-54. PubMed ID: 24925606
[TBL] [Abstract][Full Text] [Related]
2. [Subjective cognition in schizophrenia].
Potvin S; Aubin G; Stip E
Encephale; 2017 Feb; 43(1):15-20. PubMed ID: 26923995
[TBL] [Abstract][Full Text] [Related]
3. Cognitive and clinical predictors of functional capacity in patients with first episode schizophrenia.
Vesterager L; Christensen TØ; Olsen BB; Krarup G; Melau M; Forchhammer HB; Nordentoft M
Schizophr Res; 2012 Nov; 141(2-3):251-6. PubMed ID: 23017825
[TBL] [Abstract][Full Text] [Related]
4. Modafinil improves antipsychotic-induced parkinsonism but not excessive daytime sleepiness, psychiatric symptoms or cognition in schizophrenia and schizoaffective disorder: a randomized, double-blind, placebo-controlled study.
Lohr JB; Liu L; Caligiuri MP; Kash TP; May TA; Murphy JD; Ancoli-Israel S
Schizophr Res; 2013 Oct; 150(1):289-96. PubMed ID: 23938173
[TBL] [Abstract][Full Text] [Related]
5. Benzodiazepine long-term administration is associated with impaired attention/working memory in schizophrenia: results from the national multicentre FACE-SZ data set.
Fond G; Berna F; Boyer L; Godin O; Brunel L; Andrianarisoa M; Aouizerate B; Capdevielle D; Chereau I; Danion JM; Dubertret C; Dubreucq J; Faget C; Gabayet F; Le Gloahec T; Llorca PM; Mallet J; Misdrahi D; Rey R; Richieri R; Passerieux C; Portalier C; Roux P; Vehier A; Yazbek H; Schürhoff F; Bulzacka E;
Eur Arch Psychiatry Clin Neurosci; 2018 Feb; 268(1):17-26. PubMed ID: 28349247
[TBL] [Abstract][Full Text] [Related]
6. Affective symptoms in schizophrenia are strongly associated with neurocognitive deficits indicating disorders in executive functions, visual memory, attention and social cognition.
Kanchanatawan B; Thika S; Anderson G; Galecki P; Maes M
Prog Neuropsychopharmacol Biol Psychiatry; 2018 Jan; 80(Pt C):168-176. PubMed ID: 28666826
[TBL] [Abstract][Full Text] [Related]
7. Verbal working memory in schizophrenia from the Consortium on the Genetics of Schizophrenia (COGS) study: the moderating role of smoking status and antipsychotic medications.
Lee J; Green MF; Calkins ME; Greenwood TA; Gur RE; Gur RC; Lazzeroni LC; Light GA; Nuechterlein KH; Radant AD; Seidman LJ; Siever LJ; Silverman JM; Sprock J; Stone WS; Sugar CA; Swerdlow NR; Tsuang DW; Tsuang MT; Turetsky BI; Braff DL
Schizophr Res; 2015 Apr; 163(1-3):24-31. PubMed ID: 25248939
[TBL] [Abstract][Full Text] [Related]
8. Negative attitude towards medication is associated with working memory impairment in schizophrenia patients.
Goodman C; Knoll G; Isakov V; Silver H
Int Clin Psychopharmacol; 2005 Mar; 20(2):93-6. PubMed ID: 15729084
[TBL] [Abstract][Full Text] [Related]
9. A randomized controlled trial of olanzapine improving memory deficits in Han Chinese patients with first-episode schizophrenia.
Wang CH; Li Y; Yang J; Su LY; Geng YG; Li H; Wang JK; Mu JL
Schizophr Res; 2013 Mar; 144(1-3):129-35. PubMed ID: 23352776
[TBL] [Abstract][Full Text] [Related]
10. Community dysfunction in schizophrenia: rate-limiting factors.
Bozikas VP; Kosmidis MH; Kafantari A; Gamvrula K; Vasiliadou E; Petrikis P; Fokas K; Karavatos A
Prog Neuropsychopharmacol Biol Psychiatry; 2006 May; 30(3):463-70. PubMed ID: 16442195
[TBL] [Abstract][Full Text] [Related]
11. Verbal and visuospatial working memory development and deficits in children and adolescents with schizophrenia.
White T; Schmidt M; Karatekin C
Early Interv Psychiatry; 2010 Nov; 4(4):305-13. PubMed ID: 20977687
[TBL] [Abstract][Full Text] [Related]
12. Spatial working memory deficit correlates with disorganization symptoms and social functioning in schizophrenia.
Takahashi H; Iwase M; Nakahachi T; Sekiyama R; Tabushi K; Kajimoto O; Shimizu A; Takeda M
Psychiatry Clin Neurosci; 2005 Aug; 59(4):453-60. PubMed ID: 16048451
[TBL] [Abstract][Full Text] [Related]
13. Neural markers of negative symptom outcomes in distributed working memory brain activity of antipsychotic-naive schizophrenia patients.
Nejad AB; Madsen KH; Ebdrup BH; Siebner HR; Rasmussen H; Aggernæs B; Glenthøj BY; Baaré WF
Int J Neuropsychopharmacol; 2013 Jul; 16(6):1195-204. PubMed ID: 23164479
[TBL] [Abstract][Full Text] [Related]
14. Neurological soft signs in first-episode schizophrenia: State- and trait-related relationships to psychopathology, cognition and antipsychotic medication effects.
Emsley R; Chiliza B; Asmal L; Kilian S; Riaan Olivier M; Phahladira L; Ojagbemi A; Scheffler F; Carr J; Kidd M; Dazzan P
Schizophr Res; 2017 Oct; 188():144-150. PubMed ID: 28130002
[TBL] [Abstract][Full Text] [Related]
15. The influence of switching from risperidone to paliperidone on the extrapyramidal symptoms and cognitive function in elderly patients with schizophrenia: a preliminary open-label trial.
Suzuki H; Gen K; Inoue Y; Hibino H; Mikami A; Matsumoto H; Mikami K
Int J Psychiatry Clin Pract; 2014 Jan; 18(1):58-62. PubMed ID: 24047427
[TBL] [Abstract][Full Text] [Related]
16. Cognitive neuropsychological functioning in New Zealand Māori diagnosed with schizophrenia.
Kake TR; Garrett N; Te Aonui M
Aust N Z J Psychiatry; 2016 Jun; 50(6):566-76. PubMed ID: 26494850
[TBL] [Abstract][Full Text] [Related]
17. Predictors of community functioning in schizophrenia and substance use disorder patients.
Zhornitsky S; Aubin G; Desfossés J; Rizkallah E; Pampoulova T; Lipp O; Chiasson JP; Stip E; Potvin S
Community Ment Health J; 2013 Jun; 49(3):317-22. PubMed ID: 22847727
[TBL] [Abstract][Full Text] [Related]
18. A randomized controlled trial of olanzapine versus haloperidol in the treatment of primary negative symptoms and neurocognitive deficits in schizophrenia.
Lindenmayer JP; Khan A; Iskander A; Abad MT; Parker B
J Clin Psychiatry; 2007 Mar; 68(3):368-79. PubMed ID: 17388705
[TBL] [Abstract][Full Text] [Related]
19. Genetic modulation of working memory deficits by ankyrin 3 gene in schizophrenia.
Zhang C; Cai J; Zhang J; Li Z; Guo Z; Zhang X; Lu W; Zhang Y; Yuan A; Yu S; Fang Y
Prog Neuropsychopharmacol Biol Psychiatry; 2014 Apr; 50():110-5. PubMed ID: 24361380
[TBL] [Abstract][Full Text] [Related]
20. Neuropsychological performance and auditory event related potentials in schizophrenia patients and their siblings: a family study.
Şevik AE; Anıl Yağcıoğlu AE; Yağcıoğlu S; Karahan S; Gürses N; Yıldız M
Schizophr Res; 2011 Aug; 130(1-3):195-202. PubMed ID: 21592733
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
